Global Fairness in Drug Pricing Act

# Global Fairness in Drug Pricing Act Summary **What the Bill Would Do:** The Global Fairness in Drug Pricing Act would allow the federal government to negotiate drug prices for Medicare beneficiaries more directly, with the goal of reducing what seniors and the government pay for prescription medications. The bill aims to tie U.S. drug prices more closely to the prices paid in other developed countries like Canada, Germany, and Australia, where medications typically cost significantly less than in the United States. **Who It Affects:** The bill primarily affects Medicare recipients (people 65 and older), though it could indirectly impact all Americans by potentially lowering drug costs across the board.

It would also affect pharmaceutical companies, which might face reduced revenues if forced to lower prices, and could influence drug pricing strategies nationwide. **Current Status:** The bill is currently in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. This is an early stage in the legislative process, and the bill would need to pass committee, a full House vote, Senate approval, and presidential signature to become law.